Profiel
Paul Shin formerly worked at Avanir Pharmaceuticals, Inc., as Vice President-Research & Development Operations from 2011 to 2016, Intercept Pharmaceuticals, Inc., as Vice President-Global Clinical Operations from 2018 to 2020, Nestle Health Science SA, as SVP-Global Research & Development Operations from 2016 to 2018, and 89bio, Inc., as VP-Research & Development Operations from 2024 to 2025.
Mr. Shin received his undergraduate degree from the University of California.
Eerdere bekende functies van Paul Shin
| Bedrijven | Functie | Einde |
|---|---|---|
| 89BIO, INC. | Operationeel Directeur | 05-08-2024 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2020 |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
| AVANIR PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
Opleiding van Paul Shin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
89bio, Inc.
89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















